CN115433249A - Preparation method of novel stevioside derivative rebaudioside L2 - Google Patents
Preparation method of novel stevioside derivative rebaudioside L2 Download PDFInfo
- Publication number
- CN115433249A CN115433249A CN202211014098.7A CN202211014098A CN115433249A CN 115433249 A CN115433249 A CN 115433249A CN 202211014098 A CN202211014098 A CN 202211014098A CN 115433249 A CN115433249 A CN 115433249A
- Authority
- CN
- China
- Prior art keywords
- rebaudioside
- glycosyltransferase
- reaction
- yjic
- recombinant bacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229930188195 rebaudioside Natural products 0.000 title claims abstract description 65
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 title abstract description 9
- 108700023372 Glycosyltransferases Proteins 0.000 claims abstract description 37
- 102000051366 Glycosyltransferases Human genes 0.000 claims abstract description 37
- 239000001512 FEMA 4601 Substances 0.000 claims abstract description 36
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 claims abstract description 36
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 claims abstract description 36
- 235000019203 rebaudioside A Nutrition 0.000 claims abstract description 36
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims abstract description 33
- 108010043934 Sucrose synthase Proteins 0.000 claims abstract description 27
- 230000000694 effects Effects 0.000 claims abstract description 16
- 239000000126 substance Substances 0.000 claims abstract description 10
- 239000013592 cell lysate Substances 0.000 claims description 24
- 239000000047 product Substances 0.000 claims description 18
- 241000894006 Bacteria Species 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- 241000588724 Escherichia coli Species 0.000 claims description 11
- HSCJRCZFDFQWRP-JZMIEXBBSA-N UDP-alpha-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-JZMIEXBBSA-N 0.000 claims description 11
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 claims description 11
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 8
- 235000003599 food sweetener Nutrition 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 239000003765 sweetening agent Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 6
- 239000000348 glycosyl donor Substances 0.000 claims description 4
- 230000006037 cell lysis Effects 0.000 claims description 2
- 235000013305 food Nutrition 0.000 claims description 2
- 230000002194 synthesizing effect Effects 0.000 claims description 2
- 238000005859 coupling reaction Methods 0.000 abstract description 50
- 238000006243 chemical reaction Methods 0.000 abstract description 39
- 239000000758 substrate Substances 0.000 abstract description 8
- 230000015572 biosynthetic process Effects 0.000 abstract description 6
- -1 rebaudioside A monosaccharide Chemical class 0.000 abstract description 5
- 238000003786 synthesis reaction Methods 0.000 abstract description 5
- 230000002210 biocatalytic effect Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 241000219194 Arabidopsis Species 0.000 abstract 1
- 230000010933 acylation Effects 0.000 abstract 1
- 238000005917 acylation reaction Methods 0.000 abstract 1
- 230000003197 catalytic effect Effects 0.000 abstract 1
- KWVKUAKMOIEELN-UHFFFAOYSA-N ent-kaur-16-en-19-oic acid Natural products CC1(C)CCCC2(C)C1CCC34CC(=C(C3)C(=O)O)CCC24 KWVKUAKMOIEELN-UHFFFAOYSA-N 0.000 abstract 1
- NIKHGUQULKYIGE-UHFFFAOYSA-N kaurenoic acid Natural products C1CC2(CC3=C)CC3CCC2C2(C)C1C(C)(C(O)=O)CCC2 NIKHGUQULKYIGE-UHFFFAOYSA-N 0.000 abstract 1
- 238000002514 liquid chromatography mass spectrum Methods 0.000 abstract 1
- 238000005065 mining Methods 0.000 abstract 1
- 238000002436 one-dimensional nuclear magnetic resonance spectrum Methods 0.000 abstract 1
- 238000002495 two-dimensional nuclear magnetic resonance spectrum Methods 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 36
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 34
- 238000006206 glycosylation reaction Methods 0.000 description 34
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- 230000013595 glycosylation Effects 0.000 description 26
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 23
- 229930006000 Sucrose Natural products 0.000 description 23
- 239000005720 sucrose Substances 0.000 description 23
- 239000011780 sodium chloride Substances 0.000 description 17
- 108090000623 proteins and genes Proteins 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 13
- 235000019202 steviosides Nutrition 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 12
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 12
- 238000001514 detection method Methods 0.000 description 11
- 239000004383 Steviol glycoside Substances 0.000 description 10
- 235000019411 steviol glycoside Nutrition 0.000 description 10
- 229930182488 steviol glycoside Natural products 0.000 description 10
- 150000008144 steviol glycosides Chemical class 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 238000001228 spectrum Methods 0.000 description 8
- 239000012528 membrane Substances 0.000 description 7
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 238000002761 liquid phase assay Methods 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000035484 reaction time Effects 0.000 description 5
- 229960000723 ampicillin Drugs 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000000967 suction filtration Methods 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000011033 desalting Methods 0.000 description 3
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 239000012139 lysis buffer Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 150000007523 nucleic acids Chemical group 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 229940013618 stevioside Drugs 0.000 description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 241000219195 Arabidopsis thaliana Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- GIPHUOWOTCAJSR-UHFFFAOYSA-N Rebaudioside A. Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1OC(C1O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O GIPHUOWOTCAJSR-UHFFFAOYSA-N 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 2
- 102000004357 Transferases Human genes 0.000 description 2
- 108090000992 Transferases Proteins 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000005100 correlation spectroscopy Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 125000003147 glycosyl group Chemical group 0.000 description 2
- 238000000990 heteronuclear single quantum coherence spectrum Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000001896 rotating frame Overhauser effect spectroscopy Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- JUJWROOIHBZHMG-QYKNYGDISA-N 2-deuteriopyridine Chemical compound [2H]C1=CC=CC=N1 JUJWROOIHBZHMG-QYKNYGDISA-N 0.000 description 1
- 238000005084 2D-nuclear magnetic resonance Methods 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 150000001720 carbohydrates Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 201000011243 gastrointestinal stromal tumor Diseases 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 1
- 238000001052 heteronuclear multiple bond coherence spectrum Methods 0.000 description 1
- 238000005570 heteronuclear single quantum coherence Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- 238000012933 kinetic analysis Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 150000002771 monosaccharide derivatives Chemical group 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000001551 total correlation spectroscopy Methods 0.000 description 1
- SPOMEWBVWWDQBC-UHFFFAOYSA-K tripotassium;dihydrogen phosphate;hydrogen phosphate Chemical compound [K+].[K+].[K+].OP(O)([O-])=O.OP([O-])([O-])=O SPOMEWBVWWDQBC-UHFFFAOYSA-K 0.000 description 1
- 238000001195 ultra high performance liquid chromatography Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/256—Polyterpene radicals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/34—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/35—Starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/36—Terpene glycosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/82—Acid flavourants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
- C12N9/1062—Sucrose synthase (2.4.1.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01013—Sucrose synthase (2.4.1.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01081—Flavone 7-O-beta-glucosyltransferase (2.4.1.81)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a preparation method of a novel stevioside derivative rebaudioside L2, belonging to the field of biocatalytic synthesis. The invention obtains a glycosyltransferase YjiC with catalytic rebaudioside A monosaccharide acylation activity by mining, analyzes the complete structure of a product through LC-MS, 1D and 2D NMR spectra, and obtains a new product with the chemical structure of 13- [ (2-O-beta-D-glucopyranosyl-3-O-beta-D-glucopyranosyl-6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl) oxy ] ent-kaur-16-en-19-oic acid beta-D-glucopyranosyl ester. And a glycosyltransferase YjiC and a sucrose synthase AtSuSy from Arabidopsis are constructed for coupling reaction, so that the rebaudioside L2 is efficiently catalytically synthesized by taking rebaudioside A as a substrate, and 30.94g/L of rebaudioside L2 is efficiently synthesized by taking 29.01g/L (30 mmol/L) of rebaudioside A as a substrate for reaction for 12h, wherein the yield of the rebaudioside L2 reaches 91.34%, and a new efficient and green way is provided for the production of the rebaudioside L2.
Description
Technical Field
The invention relates to a preparation method of a novel stevioside derivative rebaudioside L2, belonging to the technical field of biocatalytic synthesis.
Background
In recent years, the worldwide risk of caries, obesity, diabetes, hypertension, cardiovascular disease has increased, and therefore, consumer demand for low-calorie or non-calorie sweeteners has increased. Stevioside extracted from stevia rebaudiana is considered to be the most attractive sweetener at present due to its high sweetness (50-450 times that of sucrose), non-caloric and safety. In addition, rebaudioside has also been found to have important pharmacological activities, such as lowering blood sugar, lowering blood pressure, diuresis, anti-inflammatory, anti-tumor, and immunomodulating effects. Sixty or more steviol glycosides have been discovered from stevia rebaudiana, of which stevioside (5-10% of the dry weight of the leaves) and rebaudioside a (2-4% of the dry weight of the leaves) are the two most abundant components, and are also the main components of commercially available stevioside additives on the market today. Unfortunately, the consumption of steviol glycosides can be associated with an undeniable bitter taste, which also limits the commercial use of steviol glycosides to their success.
It has now been found that the amount and position of the sugar attached to the C-13 and/or C-19 position of the steviol glycoside can significantly affect sweetness and mouthfeel, but the specific structure relationship to sweetness has not been fully resolved. A more efficient way to solve this problem is to introduce a single glycosyl unit at different positions. Therefore, related researchers have performed many chemical and biological modifications on steviol glycosides to elucidate the relationship between structure and function of steviol glycosides and expect to obtain steviol glycosides with better sweetness quality. To date, various enzymes have been reported for glycosylation modification of steviol glycosides, such as cyclodextrin glycosyltransferase, glucanase, galactosidase, glucosidase, fructosidase, etc. However, these enzymes have the disadvantages of low yield, product mix, etc., and often introduce multiple glycosyl units on the substrate simultaneously, compared with UDP-glycosyltransferase with high conversion rate and regioselectivity. Therefore, the excavation of UDP-glycosyltransferase to realize the monosaccharide glycosylation of different positions of rebaudioside A has important significance for explaining the relation between the stevioside structure and the sweet taste quality.
Disclosure of Invention
In order to solve the problems, the invention discloses a glucoside transferase YjiC from bacillus for catalyzing rebaudioside A to synthesize a mono-glycosylation derivative rebaudioside L2, wherein the glucoside transferase YjiC can realize high-efficiency soluble expression in escherichia coli and has the activity of catalyzing rebaudioside A to synthesize rebaudioside L2 in the presence of uridine diphosphate glucose (UDPG). And through constructing a uridine diphosphate glucose UDPG circulating regeneration system, efficient biosynthesis of rebaudioside L2 is realized by utilizing an escherichia coli lysate, and an effective method is provided for industrial application of rebaudioside L2.
In order to solve the technical problems, the technical scheme of the invention is as follows:
the first object of the invention is to provide a compound rebaudioside L2, wherein the chemical structural formula of the compound rebaudioside L2 is shown as follows:
it is a second object of the present invention to provide a recombinant bacterium which expresses a glycosyltransferase having an amino acid sequence having NCBI accession number WP _003232783.1.
In one embodiment, the recombinant bacterium further expresses a sucrose synthase.
In one embodiment, the amino acid sequence of the sucrose synthase may be an amino acid sequence having sucrose synthase activity from any source.
In one embodiment, the amino acid sequence of the sucrose synthase has NCBI accession No. NP _001031915.
In one embodiment, the recombinant bacterium uses escherichia coli as a host cell.
The third purpose of the invention is to provide a method for catalytically synthesizing rebaudioside L2, wherein the method uses UDP-glucose (UDPG) as a glycosyl donor to catalyze rebaudioside a to prepare and obtain rebaudioside L2; the composition is glycosyltransferase YjiC or the recombinant bacteria or one or more cell lysates of the recombinant bacteria.
In one embodiment, the method is to use rebaudioside A as a substrate and perform a catalytic reaction by using a cell lysate of the recombinant bacterium.
In one embodiment, the cell lysate is a supernatant obtained by cell lysis after the induction expression of the recombinant bacteria.
In one embodiment, the conditions of the catalytic reaction are: with 5-50mmol/L rebaudioside A, 50-800mmol/L sucrose, 5-25% (v/v) DMSO, 100mmol/L K 2 HPO 4 -KH 2 PO 4 Buffer solution, 100mmol/L NaCl as reaction system, and glycosylation reaction at 20-45 deg.C for 0-48h.
In one embodiment, the buffer has a pH of 5.5 to 9.0.
The invention also provides application of the glycosyltransferase YjiC or the recombinant bacterium or the method in preparation of a rebaudioside L2-containing product.
The fourth purpose of the invention is to provide a sweetener, wherein the sweetener contains the compound rebaudioside L2.
In one embodiment, the sweetener further comprises a flavoring agent.
In one embodiment, the flavoring agent is ribose, xylose and one or more of xylitol, glucose, sorbitol, lactose, sucrose, palatinose, trehalose, maltodextrin or starch, lactic acid, malic acid and citric acid.
The invention also provides application of the compound rebaudioside L2 or the sweetener in the fields of food, medicine or chemical industry.
Has the advantages that:
(1) The invention uses the nucleic acid sequence of the encoding glycosyltransferase YjiC to prepare the recombinant protein capable of catalyzing the glycosylation of rebaudioside A, and the prepared recombinant protein can synthesize the rebaudioside A mono-glycosylation derivative rebaudioside L2 by using UDPG as a glycosyl donor and rebaudioside A as a substrate. Provides a new analogue for clarifying the relation between the stevioside structure and the sweet taste.
(3) According to the invention, glycosyltransferase YjiC and sucrose synthase AtSuSy are combined to construct a UDPG circulating regeneration system. Through the optimization of the coupling reaction system conditions, the synthesis of 30.94g/L of rebaudioside L2 with high yield of 91.34% by using 29.01g/L (30 mmol/L) of rebaudioside A is realized.
(4) The constructed recombinant strain co-expresses glycosyltransferase derived from bacillus and sucrose synthase derived from arabidopsis thaliana, and the cell lysate prepared after the induction expression of the recombinant strain is utilized to catalyze rebaudioside A to synthesize rebaudioside L2, so that a glycosyl donor is not required to be added, and a cell penetrating agent is not required to be additionally used, so that the cost is remarkably reduced, and the method is green and environment-friendly.
Drawings
Fig. 1 shows the biosynthetic pathway for the production of rebaudioside L2 by the glycosyltransferase YjiC catalyzing rebaudioside a.
FIG. 2 shows the expression and purification analysis of the glycosyltransferase YjiC protein in example 2.
FIG. 3 is a UPLC analysis chart of the synthesis of rebaudioside L2 from rebaudioside A catalyzed by glycosyltransferase YjiC in example 3. Lane 1: marker; lane 2: no IPTG induced expression samples; lane 3: crude enzyme solution; lane 4: supernatant of the crude enzyme solution; lane 5: precipitating the crude enzyme solution; lane 6: purifying the transudate liquid; lane 7: washing the heteroprotein sample; lane 8: the protein of interest elutes the sample.
FIG. 4 is a rebaudioside L2 mass spectrometry analysis of the rebaudioside A glycosylation reaction product of example 3.
FIG. 5 is a NMR spectroscopic hydrogen spectrum of rebaudioside L2, a product of example 4.
FIG. 6 is a carbon spectrum of NMR spectroscopy analysis of rebaudioside L2, a product of example 4.
FIG. 7 is a magnetic resonance spectroscopy COSY spectrum of the product rebaudioside-L2 in example 4.
FIG. 8 is a nuclear magnetic resonance spectroscopy TOCSY spectrum of rebaudioside L2, the product of example 4.
FIG. 9 is an NMR spectroscopy HSQC spectrum of rebaudioside L2, the product of example 4.
FIG. 10 is a NMR spectroscopic HMBC spectrum of the product rebaudioside L2 of example 4.
FIG. 11 is a NMR spectroscopy ROESY spectrum of rebaudioside L2, a product of example 4.
FIG. 12 shows the protein expression analysis of lysates from YjiC-AtSuSy glycosylation coupling reaction in example 6. Lane 1: marker; lane 2: no IPTG induced expression samples; lane 3: crude enzyme solution; lane 4: supernatant of the crude enzyme solution; lane 5: and precipitating the crude enzyme solution.
FIG. 13 is a graph showing the effect of pH on buffer solutions for glycosylation coupling reactions in example 7.
FIG. 14 is a graph showing the effect of temperature on the glycosylation coupling reaction in example 8.
FIG. 15 is a graph showing the effect of DMSO concentration on the glycosylation coupling reaction in example 9.
FIG. 16 is a graph showing the effect of sucrose concentration on glycosylation coupling reaction in example 10.
FIG. 17 is a graph showing the effect of substrate concentration on glycosylation coupling reaction in example 11.
FIG. 18 shows the effect of reaction time on the glycosylation coupling reaction in example 12.
Detailed Description
The invention is further described with reference to the drawings and the following detailed description, which are not intended to limit the invention in any way. Reagents, methods and apparatus used in the present invention are conventional in the art unless otherwise indicated.
Unless otherwise specified, reagents and materials used in the following examples are all commercially available products or can be prepared by known methods.
The methods referred to in the following examples:
determination of the enzymatic properties of glycosyltransferases: kinetic analysis of rebaudioside A by glycosyltransferase YjiC was performed in a 200 μ L reaction system containing 5mM UDPG,10mM MnCl 2 50mM Bis-Tris pH 7.0 and 5 μ g purified protein sample, with rebaudioside A concentrations ranging from 0.5 to 8mM. The reaction temperature is 35 ℃, the reaction time is 20min, and the reaction is quenched by heating at 95 ℃ for 10min immediately after the reaction is finished. Diluting with 5 times volume of methanol, centrifuging at 20000 × g for 5min, and removing protein precipitate. The supernatant was filtered through a 0.22 μm filter and the sample was analyzed by UPLC.
Determination of rebaudioside L2 yield: preparing rebaudioside L2 standard solutions with different concentrations (1 mM, 2mM, 3mM, 4mM, 5mM and 6 mM), analyzing the standard solutions by using UPLC to obtain a rebaudioside L2 concentration standard curve equation of y =4450596.9x +346752.0 2 =0.99892. And (5) converting according to a standard curve to obtain the rebaudioside L2 yield. Yield = rebaudioside L2 actual yield/rebaudioside L2 theoretical yield.
Example 1 acquisition of glycosyltransferase YjiC Gene and construction of recombinant Strain
The amino acid sequence (accession number: WP _ 003232783.1) and the nucleic acid sequence (accession number: CP 053102.1) of Bacillus glycosyltransferase were downloaded from Genbank, and were genetically synthesized by Hakken Biotech Ltd and ligated to the polyclonal cleavage site of vector pET-21b (+), to obtain recombinant plasmid pET-21b (+) -YjiC.
The obtained plasmid pET-21b (+) -YjiC is subjected to sequencing identification and is transformed into a competent cell of Escherichia coli E.coli BL21 (DE 3), and an LB solid plate (10 g/L peptone, 5g/L yeast powder, 10g/L NaCl,20g/L agar powder) containing 100 mu g/mL ampicillin is adopted for screening, so that a recombinant strain E.coli BL2L (DE 3) pET-21b (+) -YjiC is obtained.
Example 2 inducible expression of recombinant Strain and purification of protein of interest
The recombinant strain E.coli BL2L (DE 3) pET-21b (+) -YjiC constructed in example 1 was inoculated into 1L 2 XYT liquid medium (16 g/L peptone, 10g/L yeast powder, 5g/L NaCl) containing 100. Mu.g/mL ampicillin and cultured at 135rpm at 37 ℃ to OD 600 After the concentration is 0.6-0.8 ℃, the culture temperature is reduced to 18 ℃, isopropyl-beta-thiogalactoside (IPTG) with the final concentration of 0.1mmol/L is added, and the induction culture is carried out for 8 hours.
The induced expression was centrifuged (7000rpm, 7min,4 ℃ C.), the supernatant was discarded, and the cells were collected. The cells were resuspended in lysis buffer (50 mmol/L Tris-HCl pH 8.0, 300mmol/L NaCl,10mmol/L imidazole, 10% glycerol) per 10mL of lysis buffer per 1g of cells. Crushing by a high-pressure homogenizer, centrifuging the crushed bacterial liquid (40000 Xg, 30 min), and taking the supernatant to obtain a crude enzyme liquid.
Using the crude enzyme solution with Ni + And (3) carrying out affinity chromatography purification on the column, after the sample loading is finished, washing the hybrid protein by 10 times of volume of lysate, and eluting the target protein by using an elution buffer (50 mmol/L Tris-HCl pH 8.0, 300mmol/L NaCl,250mmol/L imidazole and 10% glycerol). The eluted target protein was collected and desalted by Desalting column (HistrpTM 5mL desaling) with Desalting buffer (25 mmol/L Tris-HCl,150mmol/L NaCl,10% glycerol). After desalting, the mixture was concentrated to 10mg/mL and subjected to the subsequent reaction. The purified protein was detected by 10% SDS-PAGE gel electrophoresis, and the results are shown in FIG. 2, and the pure enzyme with the correct size of the band-clear protein of interest was successfully obtained. K of YjiC to rebaudioside A is measured m The value was 1.25. + -. 0.11mM cat The value was 0.71. + -. 0.02s -1 。
Example 3 glycosylation reaction of YjiC to catalyze rebaudioside A reaction to synthesize rebaudioside L2
The purified glycosyltransferase YjiC obtained in example 2 was used in the glycosylation reaction (FIG. 1).
The glycosylation reaction was carried out in a 200. Mu.L reaction system as follows: 50mmol/L Tris-HCl pH 8.0,5mmol/L UDPG,10mmol/L MnCl 2 3mmol/L rebaudioside A, the concentration of pure enzyme YjiC obtained in example 2 was 10. Mu.M. The reaction was carried out at 35 ℃ for 20min. After the reaction, the reaction mixture was diluted with 5 volumes of methanol, centrifuged at 20000 Xg for 5min, filtered through a 0.22. Mu.M filter membrane, and the filtrate was subjected to ultra-high performance liquid chromatography (UPLC) detection and analysis. UPLC used waters BEH C18.7. Mu.M reverse column, 2. Mu.L sample size, 40 ℃ column temperature, mobile phase used A line: acetonitrile, line B: 1.38g/L NaH 2 PO 4 Buffer (pH 2.6), flow rate 0.3mL/min, specific procedure as shown in Table 1:
TABLE 1UPLC reaction procedure
As can be seen from the results of liquid phase analysis, as shown in FIG. 3, when compared with rebaudioside A standard, a significant new product was produced in the reaction system, and Mass Spectrometry (MS) analysis was performed on the reaction mixture (FIG. 4), and the negative ion mode results of LC-MS showed that there was a [ M-H ] at M/z 1127.4790] - Ion peak, corresponding to formula C 50 H 80 O 28 It shows that the product is a monosaccharide derivative of rebaudioside A, with a [ M-Glc-H ] at M/z 965.4385] - Peak of ion. Since the ester bond at the C-19 position of steviol glycoside is more easily cleaved in ESI-MS to generate fragment ions, it is speculated that the new glucosyl unit is increased in the C-13-trisaccharide portion of rebaudioside A.
Example 4 structural identification of novel rebaudioside a monoglycosylated derivatives
The novel derivatives were prepared using glycosyltransferase YjiC for large scale (100 mL) glycosylation reactions under the same conditions as in example 3. Using semi-preparative high performance liquid chromatography systemsPurification was carried out using a Shim-pack GIST C18 column (10X 250mm,5 μm, SHIMADZU, japan) with a detection wavelength of 210nm, a mobile phase of a mixture of acetonitrile and water, a solvent flow rate of 5mL/min, a column temperature of 40 ℃ and an elution procedure of 0 to 35min of 26% acetonitrile isocratic elution. 85mg of high-purity product were obtained from the reaction mixture. Then, by 1D: ( 1 H and 13 c) And 2D NMR (COSY, TCOSY, HSQC, HMBC, and ROESY) spectra were analyzed for the complete structure of the product (see FIGS. 5-11). Data were collected using a Bruker Avance III 600MHz spectrometer (Bruker BioSpin, karlsruhe, germany), 1 the frequency of the H spectrum detection is 600MHz, 13 the C spectrum was 151MHz.1H-NMR has typical steviol glycoside signal characteristics. Peaks with chemical shifts less than 2.5ppm are derived from terpene aglycones and peaks with chemical shifts from 3-6ppm are derived from sugar rings.
From 1 H and 1 H- 13 the C HSQC spectrum shows delta H 6.07(δ C 95.56)、δ H 5.40(δ C 104.20)、δ H 5.25(δ C 104.32)、δ H 4.98(δ C 105.31)、δ H 4.90(δ C 97.26 Presence of 5 aberrant protons, confirming the presence of 5 saccharide units in the structure of the product. At the same time, at delta H 6.07(J=8.4Hz)、δ H 5.40(J=7.3Hz)、δ H 5.25(J=7.9Hz)、δ H 4.98(J=7.9Hz)、δ H 4.90 The observation of a high J dipole moment at (J =6.8 Hz) indicates that the 5 glucose residues are all in the beta configuration. The chemical shifts of H and C of the new derivatives were assigned in detail by 1D and 2D HMR as shown in table 2. The new product is determined to be a glucosyl group connected with the C-13 position of the core of the rebaudioside A diterpene through a beta-1, 6-bond, and the new product is named rebaudioside L2. The structural formula is 13- [ (2-O-beta-D-glucopyranosyl-3-O-beta-D-glucopyranosyl-6-O-beta-D-glucopyranosyl) oxy)]ent-kaur-16-en-19-oic acidβ-D-glucopyranosyl ester。
TABLE 2 1 H and 13 c chemical shift Chart (pyridine-d) 5 )
Example 5 construction of glycosyltransferase and sucrose synthase recombinant plasmids and recombinant strains
An amino acid sequence (accession number: NP-001031915) of a sucrose synthase AtSuSy derived from Arabidopsis thaliana and a nucleic acid sequence (accession number: NM-001036838.2) thereof were downloaded from Genbank, and codon optimization and gene synthesis were carried out with preference for Escherichia coli by York Biotechnology Ltd. The gene AtSuSy for coding sucrose synthase is connected to a polyclonal enzyme cutting site of pACYCDuet-1 to construct a recombinant plasmid pACYCDuet-1-AtSuSy, the obtained plasmid is sequenced and identified, and is co-transformed into a competent cell of Escherichia coli E.coli BL21 (DE 3) with pET-21b (+) -YjiC, an LB solid plate (10 g/L peptone, 5g/L yeast powder, 10g/L NaCl,20g/L agar powder) containing 100 mu g/mL ampicillin and 34 mu g/mL chloramphenicol is adopted for screening, and a recombinant strain E.coli BL2L (DE 3) YjiC-AtSuSy is obtained.
EXAMPLE 6 preparation of cell lysate from glycosyltransferase and sucrose synthase coupling reaction
The recombinant strain E.coli BL2l (DE 3) YjiC-AtSuSy constructed in example 5 was inoculated into 5L 2 XYT medium containing 100. Mu.g/mL ampicillin and 34. Mu.g/mL chloramphenicol, and cultured with shaking at 37 ℃ and 135 rpm. After the thallus grows to OD 600 Cooling to 18 deg.C when the value is 0.6-0.8, adding isopropyl-beta-D-thiogalactoside (IPTG) with final concentration of 0.2mM, inducing expression at 18 deg.C for 8 hr, centrifuging at 7000 Xg for 7min, collecting thallus, and treating with lysis buffer (100 mM K) 2 HPO 4 -KH 2 PO 4 (KPi) pH 8.0,100mM NaCl) three times and then resuspended. Cells were disrupted with a high pressure homogenizer. Immediately, the cells were centrifuged at 40000 Xg for 30min to remove cell debris. And taking the supernatant to obtain the cell lysate of the coupling reaction. And performing protein gel detection.
The results are shown in FIG. 12, which shows that both glycosyltransferase and sucrose synthase are well expressed. The protein concentration in the cell lysate was determined using a Nano-Drop 2000UV-Vis spectrophotometer. The prepared cell lysate is subpackaged and stored at-80 ℃, or is directly used for coupling reaction.
Example 7 Effect of pH on glycosyltransferase and sucrose synthase glycosylation coupling reactions
Placing the glycosylation coupling reaction system in buffer solutions with different pH values for reaction, and determining the influence of the pH on the glycosylation coupling reaction of glycosyltransferase and sucrose synthase, wherein the selected buffer solution is 100mmol/LBis-Tris pH 5.5-7.5 and 100mmol/L NaCl;100mmol/L KPi pH 5.5-8.0, 100mmol/L NaCl and 100mmol/L Tris-HCl pH 7.5-9.0, 100mmol/L NaCl.
Preparing a coupling reaction cell lysate as described in example 6, the glycosylation coupling reaction system was 1mL containing 40mg/mL of the coupling reaction cell lysate, 30mmol/L of rebaudioside A, 200mmol/L of sucrose and 5% DMSO (v/v), buffer; reacting for 6 hours at 35 ℃. After the reaction is finished, 5 times of methanol is added to stop the reaction, then methanol is added to dilute the reaction by 6 times, 20000 Xg is centrifuged for 5min, a 0.22 mu M filter membrane is filtered, and then UPLC is used for detection and analysis. The liquid phase assay was performed as described in example 3 and the rebaudioside L2 yield was calculated, showing that the rebaudioside L2 yield can reach 55% or more when the buffer was 100mmol/L KPi pH 7.5 and 100mmol/L NaCl (fig. 13).
EXAMPLE 8 Effect of temperature on glycosyltransferase and sucrose synthase glycosylation coupling reactions
The glycosylation coupling reaction system is placed in different temperatures (20-45 ℃) for reaction, and the influence of the temperature on the glycosylation coupling reaction of the glycosyl transferase and the sucrose synthase is measured.
Preparation of a coupling reaction cell lysate as described in example 6, the coupling reaction system was 1mL containing 40mg/mL of the coupling reaction cell lysate, 30mmol/L of rebaudioside A, 200mmol/L of sucrose, 10% DMSO (v/v) and 100mmol/L of KPi pH 7.5, 100mmol/L of NaCl, and reacted for 6h. After the reaction is finished, 5 times of methanol is added to stop the reaction, then methanol is added to dilute the reaction by 6 times, 20000 Xg is centrifuged for 5min, a 0.22 mu M filter membrane is used for suction filtration, and UPLC is used for detection and analysis. The liquid phase assay was performed as described in example 3, and the rebaudioside L2 yield was calculated, showing that the rebaudioside L2 yield can reach 50% or more when the temperature was 30-40 ℃ (fig. 14).
Example 9 Effect of DMSO concentration on glycosyltransferase and sucrose synthase glycosylation coupling reactions
Adding DMSO (5-25% (v/v)) with different concentrations into a glycosylation coupling reaction system for reaction, and determining the influence of the DMSO concentration on glycosylation coupling reaction of glycosyltransferase and sucrose synthase.
A coupling reaction cell lysate is prepared as described in example 6, and the coupling reaction system is 1mL, which contains 40mg/mL of coupling reaction cell lysate, 30mmol/L of rebaudioside A, 200mmol/L of sucrose, DMSO (5% -25% (v/v)), and 100mmol/L of KPi pH 7.5, 100mmol/L of NaCl, and reacts for 6h at 35 ℃. After the reaction is finished, 5 times of methanol is added to stop the reaction, then the reaction is diluted by 6 times, 20000 Xg is centrifuged for 5min, a filter membrane of 0.22 mu M is used for suction filtration, and UPLC is used for detection and analysis. The liquid phase assay was performed as described in example 3 and the rebaudioside L2 yield was calculated, showing that the rebaudioside L2 yield can reach more than 55% when the DMSO concentration was between 5% and 10% (v/v) (fig. 15).
Example 10 Effect of sucrose concentration on the coupling reaction of glycosyltransferase and sucrose synthase
Adding sucrose (50-800 mmol/L) with different concentrations into a glycosylation coupling reaction system for reaction, and determining the influence of the sucrose concentration on glycosylation coupling reaction of glycosyl transferase and sucrose synthase.
A coupled reaction cell lysate is prepared as described in example 6, wherein the coupled reaction system is 1mL, and the coupled reaction cell lysate contains 40mg/mL of coupled reaction cell lysate, 30mmol/L of rebaudioside A, sucrose (50-800 mmol/L), 10% (v/v) DMSO and 100mmol/L KPi, pH 7.5, 100mmol/L NaCl, and the reaction is carried out at 35 ℃ for 6h. After the reaction is finished, 5 times of methanol is added to stop the reaction, then the reaction is diluted by 5 times, 20000 Xg is centrifuged for 5min, a 0.22 mu M filter membrane is used for suction filtration, and detection and analysis are carried out by UPLC. The liquid phase assay was performed as described in example 3, and the rebaudioside L2 yield was calculated, showing that the rebaudioside L2 yield can reach more than 60% when the sucrose concentration was 250-600 mmol/L (fig. 16).
Example 11 Effect of rebaudioside A concentration on glycosyltransferase and sucrose synthase coupling reaction substrates
Adding rebaudioside A (5-50 mmol/L) with different concentrations into a glycosylation coupling reaction system for reaction, and determining the influence of sucrose concentration on glycosylation coupling reaction of glycosyl transferase and sucrose synthase.
A coupled reaction cell lysate is prepared as described in example 6, and the coupled reaction system is 1mL, which contains 40mg/mL coupled reaction cell lysate, rebaudioside A (5-50 mmol/L), 500mmol/L sucrose, 10% (v/v) DMSO, and 100mmol/L KPi pH 7.5, 100mmol/L NaCl, and reacts for 6h at 35 ℃. After the reaction is finished, 5 times of methanol is added to stop the reaction, then the reaction is diluted by 5 times, 20000 Xg is centrifuged for 5min, a 0.22 mu M filter membrane is used for suction filtration, and detection and analysis are carried out by UPLC. The liquid phase detection method was performed as described in example 3, and the yield of rebaudioside L2 was calculated, and the results showed that 24.00g/L of rebaudioside L2 was obtained at a yield of 70.86% at a substrate concentration of 30mmol/L (fig. 17).
EXAMPLE 12 Effect of reaction time on glycosyltransferase and sucrose synthase coupling reactions
The glycosylation coupling reaction system is reacted for different time (0-24 h), and the influence of the sucrose concentration on the glycosylation coupling reaction of the glycosyltransferase and the sucrose synthase is measured.
The coupling reaction cell lysate is prepared as described in example 6, the coupling reaction system is 20mL, and the coupling reaction cell lysate contains 40mg/mL coupling reaction cell lysate, 30mmol/L rebaudioside A, 400mmol/L sucrose, 10% (v/v) DMSO, 100mmol/L KPi pH 7.5 and 100mmol/L NaCl, and the reaction is carried out at 35 ℃, and the optimized range of the reaction time is 0-24h. After the reaction is finished, 5 times of methanol is added to stop the reaction, then the reaction is diluted by 5 times, 20000 Xg is centrifuged for 5min, and the filtration membrane with the volume of 0.22 mu M is filtered and then the detection and analysis are carried out by Ultra Performance Liquid Chromatography (UPLC). The liquid phase assay method was performed as described in example 3 and the rebaudioside L2 yield was calculated and the results showed that finally at a reaction time of 12h, 30.94g/L rebaudioside L2 was obtained at a yield of 91.34% at a rebaudioside a concentration of 30mmol/L (fig. 18).
Example 13 sweetness testing of rebaudioside L2
Sweetness testing of rebaudioside L2 was performed using sucrose as a control. Sucrose samples were purchased from pharmaceutical group, ltd, china. Wherein the purity of the rebaudioside L2 is 95 percent.
Three different concentrations of aqueous sucrose solutions were prepared at room temperature as controls: 1%, 5%, 10% (w/v). And 150 and 300ppm rebaudioside L2 aqueous solutions were prepared. 10mL of each sample solution was sampled in a 30mL disposable drinking cup, and 9 trained and experienced volunteers were subjected to sweetness evaluation (blind evaluation), and the evaluation results were averaged from the scores of the volunteers. In the evaluation, the sweetness is measured by 10 points (the sweetness is 10 points as 10% of sucrose, 5 points as 5% of sucrose, and so on) with 10 mass percent of sucrose aqueous solution, and the sweetness is 0 point which can not be detected completely.
Blind scoring results show that the sweetness scores for rebaudioside L2 at two different concentrations (150 and 300 ppm) are consistent, being 4.5 and 9.2, respectively. The results indicate that rebaudioside L2 is about 300 times more sweet than sucrose.
Although the present invention has been described with reference to the preferred embodiments, it should be understood that various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
Claims (10)
2. a recombinant bacterium which expresses glycosyltransferase YjiC; the glycosyltransferase YjiC has the amino acid sequence with NCBI accession number WP _003232783.1.
3. The recombinant bacterium of claim 2, wherein the recombinant bacterium further expresses a sucrose synthase.
4. The recombinant bacterium according to claim 3, wherein the amino acid sequence of sucrose synthase is an amino acid sequence having sucrose synthase activity from any source.
5. The recombinant bacterium according to any one of claims 2 to 4, wherein Escherichia coli is used as a host cell.
6. The method for catalytically synthesizing rebaudioside L2 is characterized in that UDP-glucose is used as a glycosyl donor, and the rebaudioside A is catalyzed into rebaudioside L2 by using the composition; the composition is one or more of glycosyltransferase YjiC, the recombinant bacterium according to any one of claims 2 to 4, or a cell lysate of the recombinant bacterium according to any one of claims 2 to 4.
7. The method of claim 6, wherein the cell lysate is a supernatant obtained by cell lysis after the recombinant bacterium is induced to express.
8. A sweetener comprising the compound rebaudioside L2 according to claim 1.
9. The compound of claim 1, rebaudioside L2, or the sweetener of claim 8, for use in the food, pharmaceutical, or chemical arts.
10. Use of a glycosyltransferase YjiC or a recombinant bacterium according to any one of claims 2 to 4 or a method according to claim 6 or 7 for the preparation of a rebaudioside L2-containing product; the glycosyltransferase YjiC has the amino acid sequence with NCBI accession number WP _003232783.1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211014098.7A CN115433249A (en) | 2022-08-23 | 2022-08-23 | Preparation method of novel stevioside derivative rebaudioside L2 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211014098.7A CN115433249A (en) | 2022-08-23 | 2022-08-23 | Preparation method of novel stevioside derivative rebaudioside L2 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115433249A true CN115433249A (en) | 2022-12-06 |
Family
ID=84244215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211014098.7A Pending CN115433249A (en) | 2022-08-23 | 2022-08-23 | Preparation method of novel stevioside derivative rebaudioside L2 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115433249A (en) |
-
2022
- 2022-08-23 CN CN202211014098.7A patent/CN115433249A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210254116A1 (en) | High-purity steviol glycosides | |
EP3193636B1 (en) | High-purity steviol glycosides | |
CN109750072B (en) | Method for preparing rebaudioside E by enzyme method | |
Lobov et al. | Enzymic production of sweet stevioside derivatives: transglucosylation by glucosidases | |
EP2645847B1 (en) | Microbial production of natural sweeteners, diterpenoid steviol glycosides | |
KR101404728B1 (en) | A method for preparation of Rebaudioside A from stevioside | |
CN110191643B (en) | Biosynthesis production of steviol glycoside and process thereof | |
CN113683712B (en) | Steviol glycosides | |
CN106834389B (en) | Method for preparing rebaudioside M2 by catalyzing rebaudioside A through recombinant bacteria | |
US20210381019A1 (en) | Biosynthetic production of variant steviol glycosides | |
CA3120867A1 (en) | High-purity steviol glycosides | |
JP2022520257A (en) | High-purity steviol glycoside | |
KR101997597B1 (en) | Synthesis method of stevioside glucosides using modified Leuconostoc and Novel stevioside glucosides made by the same | |
CN112512337A (en) | High purity steviol glycosides | |
CN113862319A (en) | Application of ginseng glycosyltransferase in synthesis of stevioside | |
Ping et al. | Efficient synthesis of rebaudioside D2 through UGT94D1-catalyzed regio-selective glycosylation | |
CN115433249A (en) | Preparation method of novel stevioside derivative rebaudioside L2 | |
CN115433702A (en) | Method for efficiently biosynthesizing rebaudioside D2 by utilizing glycosyltransferase | |
CN117343117A (en) | Preparation method of novel stevioside derivative rebaudioside M8 | |
CN117106685A (en) | Method for efficiently biosynthesizing rebaudioside M2 by utilizing glycosyltransferase | |
US20230413865A1 (en) | High-purity steviol glycosides | |
CN115478060B (en) | Glycosyltransferase and application thereof | |
KR20210130539A (en) | Method for producing α-glucosyl stevioside by dextran sucrase from Leuconostoc kimchii | |
CN118562757A (en) | Glycosyltransferase UGT76G1 mutant and application thereof in synthesis of rebaudioside M | |
CN116162607A (en) | Stevioside glycosyltransferase gene, and encoding product and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240529 Address after: No.19, Renmin South Road, Lingui District, Guilin City, Guangxi Zhuang Autonomous Region Applicant after: GUILIN LAYN NATURAL INGREDIENTS Corp. Country or region after: China Address before: No. 1800 road 214122 Jiangsu Lihu Binhu District City of Wuxi Province Applicant before: Jiangnan University Country or region before: China |
|
TA01 | Transfer of patent application right |